https://www.nature.com/articles/s41467-024-45641-0?error=cookies_not_supported&code=679dd252-ea2e-4f7e-a10d-948f71c14f2c
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult...
Feb 23, 2024 - Viral clearance, antibody response and the mutagenic effect of molnupiravir has not been elucidated in at-risk populations. Non-hospitalised participants...
sars cov 2at riskcontrolledtrialmolnupiravir
https://www.nature.com/articles/s41586-023-06649-6?error=cookies_not_supported&code=eb81cc62-1316-4a9d-969e-92238f337eda
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes | Nature
Sep 25, 2023 - Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus...
sars cov 2molnupiravirassociatedsignatureglobal
https://drugdiscovery.emory.edu/molnupiravir/index.html
About Molnupiravir | Emory University | Atlanta GA
emory universityatlanta gamolnupiravir